EBS loses money despite collecting $26 million for the quarter

[Guest guest]

http://www.lsj.com/apps/pbcs.dll/article?AID=/20070509/

NEWS03/705090357/1001/news

Published May 9, 2007

Emergent BioSolutions cuts loss

(Share price drops to 10.67. Bioport somehow lost money despite more

than doubling sales: investors may be learning the company is not to

be trusted--Nass)

W. Steele

Lansing State Journal

Emergent BioSolutions Inc., which operates a vaccine manufacturing

facility in Lansing, today reported a first-quarter loss despite

doubling its revenue.

The Rockville, Md.-based company reported it lost $2.7 million, or 10

cents a share, during the first three months of the year. That's less

than the $4.6 million, or 21 cents per share, it lost during the same

period in 2006.

Revenue was $26.4 million in the most recent quarter, up from $12.2

million one year earlier.

Officials attributed the revenue boost to the delivery of 1.1 million

doses of its BioThrax anthrax vaccine, which is made in Lansing, for

the departments of Defense and Health and Human Services. Emergent

employs about 300 people at its north Lansing facility, the former

BioPort Corp.

Company officials expect Emergent to post a profit for the year on

revenue growth of 10 to 15 percent.

Emergent, which went public last year, had revenue of $152.7 million

in 2006 and posted a $22.8 million profit for the year.

Contact W. Steele at 377-1015 or jwsteele@....

Copyright 2007 Lansing State Journal Use of this site signifies your

agreement to the

Terms of Service (updated August 2006)

[back]

Meryl Nass, MD

Mount Desert Island Hospital

Bar Harbor, Maine 04609

207 288-5081 ext. 220